Vaxart Statistics
Total Valuation
Vaxart has a market cap or net worth of $106.52 million. The enterprise value is $85.14 million.
Important Dates
The last earnings date was Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vaxart has 227.95 million shares outstanding. The number of shares has increased by 41.57% in one year.
| Current Share Class | 227.95M |
| Shares Outstanding | 227.95M |
| Shares Change (YoY) | +41.57% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 11.98% |
| Float | 226.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.14 |
| Forward PS | n/a |
| PB Ratio | 2.34 |
| P/TBV Ratio | 2.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.45.
| Current Ratio | 0.64 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.25 |
Financial Efficiency
Return on equity (ROE) is -114.74% and return on invested capital (ROIC) is -49.08%.
| Return on Equity (ROE) | -114.74% |
| Return on Assets (ROA) | -28.90% |
| Return on Invested Capital (ROIC) | -49.08% |
| Return on Capital Employed (ROCE) | -95.18% |
| Revenue Per Employee | $451,381 |
| Profits Per Employee | -$553,543 |
| Employee Count | 105 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Vaxart has paid $310,000 in taxes.
| Income Tax | 310,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.64% in the last 52 weeks. The beta is 1.28, so Vaxart's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | -43.64% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 0.65 |
| Relative Strength Index (RSI) | 55.44 |
| Average Volume (20 Days) | 1,790,846 |
Short Selling Information
The latest short interest is 14.35 million, so 6.29% of the outstanding shares have been sold short.
| Short Interest | 14.35M |
| Short Previous Month | 12.05M |
| Short % of Shares Out | 6.29% |
| Short % of Float | 6.35% |
| Short Ratio (days to cover) | 5.99 |
Income Statement
In the last 12 months, Vaxart had revenue of $47.40 million and -$58.12 million in losses. Loss per share was -$0.27.
| Revenue | 47.40M |
| Gross Profit | -26.82M |
| Operating Income | -57.16M |
| Pretax Income | -75.38M |
| Net Income | -58.12M |
| EBITDA | -48.24M |
| EBIT | -57.16M |
| Loss Per Share | -$0.27 |
Full Income StatementBalance Sheet
The company has $41.94 million in cash and $20.56 million in debt, giving a net cash position of $21.38 million or $0.09 per share.
| Cash & Cash Equivalents | 41.94M |
| Total Debt | 20.56M |
| Net Cash | 21.38M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 45.62M |
| Book Value Per Share | 0.20 |
| Working Capital | -35.86M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$33.17 million and capital expenditures -$553,000, giving a free cash flow of -$33.73 million.
| Operating Cash Flow | -33.17M |
| Capital Expenditures | -553,000 |
| Free Cash Flow | -33.73M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
Gross margin is -56.58%, with operating and profit margins of -120.60% and -122.63%.
| Gross Margin | -56.58% |
| Operating Margin | -120.60% |
| Pretax Margin | -121.98% |
| Profit Margin | -122.63% |
| EBITDA Margin | -101.78% |
| EBIT Margin | -120.60% |
| FCF Margin | n/a |